1-(4-Chlorobenzhydryl)piperazine
- Product Name
- 1-(4-Chlorobenzhydryl)piperazine
- CAS No.
- 303-26-4
- Chemical Name
- 1-(4-Chlorobenzhydryl)piperazine
- Synonyms
- Norchlorcyclizine;Hydroxyzine Related CoMpound A;1-[(4-CHLORO-PHENYL)-PHENYL-METHYL]-PIPERAZINE;NSC 8616;USP CBHP;NSC 86164;UNII:T875VN0D6E;AKOS BBS-00003606;Cetirizine USP A;TIMTEC-BB SBB002998
- CBNumber
- CB6297354
- Molecular Formula
- C17H19ClN2
- Formula Weight
- 286.8
- MOL File
- 303-26-4.mol
1-(4-Chlorobenzhydryl)piperazine Property
- Melting point:
- 65-70 °C (lit.)
- Boiling point:
- 178-180 °C/0.5 mmHg (lit.)
- Density
- 1.0912 (rough estimate)
- vapor pressure
- 0Pa at 25℃
- refractive index
- 1.5749 (estimate)
- Flash point:
- >230 °F
- storage temp.
- 2-8°C
- solubility
- soluble in Methanol
- form
- Crystalline Powder
- pka
- 8.99±0.10(Predicted)
- color
- White to light beige
- Water Solubility
- 144.6mg/L at 25℃
- LogP
- 3.4 at 25℃
- CAS DataBase Reference
- 303-26-4(CAS DataBase Reference)
- NIST Chemistry Reference
- Piperazine, 1-[(4-chlorophenyl)phenylmethyl]-(303-26-4)
Safety
- Hazard Codes
- Xi
- Risk Statements
- 36/37/38
- Safety Statements
- 26-37/39-24/25
- WGK Germany
- 3
- RTECS
- TL1772000
- Hazard Note
- Irritant
- HS Code
- 29339900
Hazard and Precautionary Statements (GHS)
- Symbol(GHS)
-
- Signal word
- Danger
- Hazard statements
-
H315Causes skin irritation
H317May cause an allergic skin reaction
H318Causes serious eye damage
- Precautionary statements
-
P201Obtain special instructions before use.
P202Do not handle until all safety precautions have been read and understood.
P280Wear protective gloves/protective clothing/eye protection/face protection.
P302+P352IF ON SKIN: wash with plenty of soap and water.
P305+P351+P338IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continuerinsing.
P308+P313IF exposed or concerned: Get medical advice/attention.
N-Bromosuccinimide Price
- Product number
- PHR2872
- Product name
- Hydroxyzine Related Compound A
- Purity
- pharmaceutical secondary standard, certified reference material
- Packaging
- 50MG
- Price
- $461
- Updated
- 2024/03/01
- Product number
- C24507
- Product name
- 1-(4-Chlorobenzhydryl)piperazine
- Purity
- technical grade, 90%
- Packaging
- 1g
- Price
- $53.2
- Updated
- 2024/03/01
- Product number
- 1333058
- Product name
- Hydroxyzine Related Compound A
- Purity
- United States Pharmacopeia (USP) Reference Standard
- Packaging
- 25mg
- Price
- $1490
- Updated
- 2024/03/01
- Product number
- C1611
- Product name
- 1-(4-Chlorobenzhydryl)piperazine
- Purity
- >98.0%(GC)
- Packaging
- 1g
- Price
- $47
- Updated
- 2024/03/01
- Product number
- C1611
- Product name
- 1-(4-Chlorobenzhydryl)piperazine
- Purity
- >98.0%(GC)
- Packaging
- 5g
- Price
- $136
- Updated
- 2024/03/01
1-(4-Chlorobenzhydryl)piperazine Chemical Properties,Usage,Production
Chemical Properties
White Solid
Uses
A metabolite of Cetirizine (C281100) and Hydroxyzine. Citirizine impurity A.
Uses
Cetrizine Dihydrochloride intermediate
Preparation
Preparation of 1-[(4-chlorophenyl)phenylmethyl]piperazine. (CPMP)
About 0.5 mL of DMF, 0.1 g of KI and 10 g (0.12 mol) of piperazine were mixed with 15 mL of toluene and heated to 80oC for 0.5 h. This mixture at 80oC was mixed with 4-CBC in toluene and the temperature was maintained at 80oC for a period of 2 h followed by refluxing at the same temperature for 12h. The reaction mixture was then cooled to 20oC. The toluene layer was washed twice with 20 mL of water and treated with HCl (15 mL conc. HCl in 5mL of water) at 5-10oC. The reaction mixture was filtered and the aqueous layer was separated from the filtrate. About 10 mL of toluene and 10 mL of methylene dichloride (MDC) washes were given to the aqueous layer and neutralized with 22 mL of 30 % NaOH solution at 10oC and maintained at 20oC for 2h. The solid compound formed was filtered, sucked and dried at 50oC for 3 h.Yield: 92 %; m.p: 63-65oC.
Flammability and Explosibility
Not classified
Safety Profile
An experimental teratogen.Experimental reproductive effects. When heated todecomposition it emits very toxic fumes of NOx and Clí.
1-(4-Chlorobenzhydryl)piperazine Preparation Products And Raw materials
Raw materials
Preparation Products
1-(4-Chlorobenzhydryl)piperazine Suppliers
- Tel
- 021-58892003
- info@qiaochem.com
- Country
- China
- ProdList
- 5904
- Advantage
- 65
- Tel
- 0513-82104991 18912868361
- Fax
- QQ1907456386
- sales11@btcpharm.com
- Country
- China
- ProdList
- 1333
- Advantage
- 58
- Tel
- 021-021-50630626 18964684208
- Fax
- 021-50563898
- kate@tajilin.com
- Country
- China
- ProdList
- 1232
- Advantage
- 58
- Tel
- 010-82848833 400-666-7788
- Fax
- 86-10-82849933
- jkinfo@jkchemical.com
- Country
- China
- ProdList
- 94657
- Advantage
- 76
- Tel
- 021-61259108 18621169109
- Fax
- 86-21-61259102
- market03@meryer.com
- Country
- China
- ProdList
- 40228
- Advantage
- 62
- Tel
- +49 3493/605464
- Fax
- +49 3493/605470
- sales@intatrade.de
- Country
- Germany
- ProdList
- 3572
- Advantage
- 66
- Tel
- 400-6106006
- Fax
- 021-67582001/03/05
- saleschina@alfa-asia.com
- Country
- China
- ProdList
- 30123
- Advantage
- 84
- Tel
- +86 351 7031519
- Fax
- +86 351 7031519
- sales@RHFChem.com
- Country
- China
- ProdList
- 2338
- Advantage
- 56
- Tel
- 021-67121386
- Fax
- 021-67121385
- Sales-CN@TCIchemicals.com
- Country
- China
- ProdList
- 24529
- Advantage
- 81
- Tel
- 021-021-58432009 400-005-6266
- Fax
- 021-58436166
- sales8178@energy-chemical.com
- Country
- China
- ProdList
- 44688
- Advantage
- 61
View Lastest Price from 1-(4-Chlorobenzhydryl)piperazine manufacturers
- Product
- 1-(4-Chlorobenzhydryl)piperazine 303-26-4
- Price
- US $0.00/kg
- Min. Order
- 1kg
- Purity
- 0.99
- Supply Ability
- 20tons
- Release date
- 2023-10-08
- Product
- 1-(4-Chlorobenzhydryl)piperazine 303-26-4
- Price
- US $0.00/kg
- Min. Order
- 1kg
- Purity
- 98%
- Supply Ability
- 200kg
- Release date
- 2022-12-13
- Product
- 1-(4-Chlorobenzhydryl)piperazine 303-26-4
- Price
- US $1.00/KG
- Min. Order
- 1KG
- Purity
- 99%
- Supply Ability
- 2000ton
- Release date
- 2024-05-07